Iniciaste sesión como:
filler@godaddy.com
Wet lab CORPAVET
CORPAVET (www.corpavet.com) is a Contract Research Organization (CRO) specializing in the development of vaccines for freshwater fish. We operate a wet lab dedicated to testing vaccine safety, immunogenicity, and efficacy. Our core capabilities include Animal Models and Target Animal Trials, Cell Line/Strain Development, Biobanking, and comprehensive Regulatory and Strategic Support. We have successfully participated in the development, registration, and regulatory consulting for several vaccine-related pharmaceuticals across Mexico, Central America, Colombia, Perú, and Brazil.
Capabilities
Wet lab for testing safety, immunogenicity, and efficacy of vaccines for freshwater fish species.
The wet lab has an ISO17025 quality system, and it is audited by the Colombian Animal Health Authority (Instituto Colombiano Agropecuario ICA)
Infrastructure (R&D, DS)
R&D infrastructure specifically in these areas:
Animal Models and Target Animal Trials: Access to suitable aquatic animal models (tilapia, trout, and Piaractus) for early studies, and facilities for controlled studies in target species to demonstrate proof-of-concept and safety.
Regulatory and Strategic Support: Support for navigating regulatory requirements, developing target product profiles (TPPs), and providing regulatory advice for veterinary products.
DS infrastructure
Cell Line/Strain Development: Maintaining cell lines (primary cell line from tilapia, and E-11)
Species focus (aquaculture)
Freshwater fish
Pathogens (bacteria, viruses)
Biobanking:
- Tilapia Lake Virus (TiLV)
- Streptococcus agalactiae Ia
- Streptococcus agalactiae Ia2021
- Streptococcus agalactiae Ib
- Edwardsiella tarda
- Edwardsiella anguillarum
- Aeromonas hydrophila
- Flavobacterium oreochromis
- Flavobacterium psychrophilum